Citation Impact
Citing Papers
Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome
2006
Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure
2013
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Trends in Antifungal Susceptibility among Swedish Candida Species Bloodstream Isolates from 1994 to 1998: Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A Reference Method
2001
Emergence of Nosocomial Candidemia at a Teaching Hospital in Taiwan from 1981 to 2000: Increased Susceptibility of Candida Species to Fluconazole
2002
β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin
2001 Standout
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
Incorporation of amphotericin B into large unilamellar vesicles composed of phosphatidylcholine and phosphatidylglycerol
1990
Linkage of Rieger syndrome to the region of the epidermal growth factor gene on chromosome 4
1992
Biopharmaceutical aspects of lipid formulations of amphotericin B
1997
Molecular mechanisms of antibiotic resistance
2014 Standout
Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome
1996 Standout
Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density
1992
Perinatal Lethality and Multiple Craniofacial Malformations in MSX2 Transgenic Mice
1997 StandoutNobel
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Glucan synthase inhibitors as antifungal agents
2001
The Failing Heart — An Engine Out of Fuel
2007 Standout
The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active Surveillance
1999
Systemically Administered Antifungal Agents
1992
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
2000 Standout
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
1999
Liposomen
1997
The gene for achondroplasia maps to the telomeric region of chromosome 4p
1994
Targeting of Liposomes to Tumor Cells in Vivoa
1987
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
2002 Standout
Epidemiology of invasive candidiasis
2010
Association of MSX1 and TGFB3 with Nonsyndromic Clefting in Humans
1998
Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay
1990
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
2003
Review of the safety and efficacy of voriconazole
2002
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases
1998
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
1995 Standout
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family
1997 Standout
Echinocandin antifungal drugs
2003 Standout
Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease
1993
Animal Models: Usefulness for Studies of Fungal Pathogenesis and Drug Efficacy in Aspergillosis
1992
Genetic heterogeneity in adult dominant polycystic kidney disease in Cypriot families
1995
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Neo‐ligands for innate immune receptors and the etiology of sterile inflammatory disease
2007 StandoutNobel
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Has Antifungal Susceptibility Testing Come of Age?
2002
Chemoembolisation in regional cancer chemotherapy: a rationale
1987
Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia
1999
Liposomes in Drug Delivery
1993
Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family
1995
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)
2012 Standout
Staphylococcus aureus Small Colony Variants in Prosthetic Joint Infection
2006
Antifungal Susceptibility Testing: Technical Advances and Potential Clinical Applications
1997
A human chromosome 7 yeast artificial chromosome (YAC) resource: construction, characterization, and screening
1995
Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B
1998
Phenotypic detection of mecC-MRSA: cefoxitin is more reliable than oxacillin
2013
A human MSX1 homeodomain missense mutation causes selective tooth agenesis
1996
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Knocking down barriers: advances in siRNA delivery
2009 Standout
Amphotericin B resistance testing of Candida spp.: a comparison of methods
1997
The TNF and TNF Receptor Superfamilies
2001 Standout
Amphotericin B: 30 Years of Clinical Experience
1990
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator
1997
A genetic linkage map of the chromosome 4 short arm
1993
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
How do the polyene macrolide antibiotics affect the cellular membrane properties?
1986
Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest
2001
Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.
1996 StandoutNobel
Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program
2004
Antifungal Susceptibility ofCandidaBiofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
2002
Contemporary Tools for the Diagnosis and Management of Invasive Mycoses
2006
Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q23
1993
Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis
1998
Current and Emerging Azole Antifungal Agents
1999 Standout
Shrink-Wrap Vesicles
2005 StandoutNobel
Coordinated Transcriptional Regulation of theunc-25Glutamic Acid Decarboxylase and theunc-47GABA Vesicular Transporter by theCaenorhabditis elegansUNC-30 Homeodomain Protein
1999 StandoutNobel
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
1996 StandoutScience
Amphotericin B lipid complex therapy of experimental fungal infections in mice
1991
Invasive Candidiasis
2015 Standout
Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts
2003
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Mitochondrial Diseases in Man and Mouse
1999 StandoutScience
Long-Circulating Immunoliposomal Amphotericin B against Invasive Pulmonary Aspergillosis in Mice
1998
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B
1997
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus
2004
Refining the localization of the PKD2 locus on chromosome 4q by linkage analysis in Spanish families with autosomal dominant polycystic kidney disease type 2.
1995
Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins
1993
Aspergillus fumigatusand Aspergillosis
1999 Standout
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
1988
In vitrogrowth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistantCandidaisolates: influence of assay conditions
1997
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
2008
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
1985
Antibiotic Susceptibility Pattern of Mycobacterium marinum
2000
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Echinocandins: role in antifungal therapy, 2005
2005
Targeted drug delivery
1986
Liposomes as carriers of antimicrobial agents
1987
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis
1994
Guidelines for Treatment of Candidiasis
2004 Standout
Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species
2004
Liposomal Amphotericin B in the Treatment of Fungal Infections
1986
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2
2005
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Detection of Resistance to Amphotericin B in Candida Isolates by Using Iso-Sensitest Broth
2001
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia
1997
Carrier effects on biological activity of amphotericin B
1996
In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp
2002
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Clinical Translation of Nanomedicine
2015
Creatine and Creatinine Metabolism
2000 Standout
Correlation between In Vitro Susceptibility Determined by E Test and Response to Therapy with Amphotericin B: Results from a Multicenter Prospective Study of Candidemia
1999
Works of K. Mills being referenced
Characterization of the human HOX 7 cDNA and identification of polymorphic markers
1992
The Ant1 gene maps near Klk3 on proximal mouse Chromosome 8
1996
Genetic and physical maps of human chromosome 4 based on dinucleotide repeats
1992
Construction of a human chromosome 4 YAC pool and analysis of artificial chromosome stability
1992
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates
1995
In Vitro Susceptibility Testing of Filamentous Fungi: Comparison of Etest and Reference Microdilution Methods for Determining Itraconazole MICs
2000
Evaluation of the Etest Method for Determining Voriconazole Susceptibilities of 312 Clinical Isolates of Candida Species by Using Three Different Agar Media
2000
Phenotypic Detection of Methicillin Resistance in Staphylococcus aureus by Disk Diffusion Testing and Etest on Mueller-Hinton Agar
2006
Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B
1983
Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species
2001
Evaluation of Etest Method for Determining Posaconazole MICs for 314 Clinical Isolates of Candida Species
2001
Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest
1996
Selective Toxicity and Enhanced Therapeutic Index of Liposomal Polyene Antibiotics in Systemic Fungal Infections
1985
In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B
1984
Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells
1984